drugset / Trial / NCT01130103

Combination Treatment for Posttraumatic Stress Disorder (PTSD) After the World Trade Center (WTC) Attack

NCT01130103

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized controlled trial evaluates efficacy of combined prolonged exposure (PE) and the selective serotonin reuptake inhibitor (SSRI) paroxetine in the treatment of survivors of the World Trade Center (WTC) attacks.

Timeline

Start
2004-03
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Paroxetine Small molecule 12.5 mg
Subject Paroxetine Small molecule 50 mg